drugset / Trial / NCT07516769

Nicorandil as Anti-inflammatory in Rheumatoid Arthritis

NCT07516769

Phase 3 Recruiting 46 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to evaluate the possible efficacy and safety of nicorandil as anti-inflammatory in managing patients with active rheumatoid arthritis.

Timeline

Start
2024-11-01
Primary completion
2027-03
Completion
2027-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicorandil Other / unclassified 5 mg Oral

Indications